Newly diagnosed epithelial adenocarcinoma of ovarian, fallopian tube, or peritoneal origin; Stage III or IV; high-grade serous adenocarcinoma, high-grade endometrioid adenocarcinoma, undifferentiated carcinoma, clear cell adenocarcinoma, mixed epithelial carcinoma, or adenocarcinoma not otherwise specified; completed debulking surgery (must be optimal); preoperative CA-125 > 50; adequate bone marrow function. This evidence concerns the gene MUC16 and clear cell adenocarcinoma.